Literature DB >> 19806390

Evaluating safety, effectiveness, and user satisfaction of home international normalized ratio monitoring service: experience from a tertiary pediatric cardiology unit in the United Kingdom.

Deepti Bhat1, Ajay Upponi, Aditya Rakecha, John Thomson.   

Abstract

Home international normalized ratio (INR) monitors are being increasingly used for monitoring the adequacy of anticoagulation in children on long-term warfarin. Their safety and effectiveness in the home setting has not been fully established. The purpose of this study was to explore the safety and effectiveness of home INR monitoring service in managing anticoagulation in children with congenital heart disease. At the Pediatric Cardiology Regional Referral Center, we studied records of 41 children on warfarin and assessed the control of anticoagulation and frequency of adverse reactions over a 1-year period. User satisfaction was assessed by means of telephone interviews. The study found that the therapeutic INR range was maintained for over 57% of the total study period. There were no reported instances of major or minor hemorrhages. On six occasions, subtherapeutic INR levels necessitated hospitalization for heparinization. Mitral valve replacement was significantly associated with poor control (p < 0.05). User satisfaction was high for all aspects of the service evaluated. The hospital-assisted home INR monitoring service is a safe and effective means of managing anticoagulation in children. In addition, it ensures good compliance and a high level of user satisfaction.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19806390     DOI: 10.1007/s00246-009-9535-x

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  7 in total

1.  Accuracy and clinical utility of the CoaguChek XS portable international normalised ratio monitor in a pilot study of warfarin home-monitoring.

Authors:  Luke R Bereznicki; Shane L Jackson; Gregory M Peterson; Ella C Jeffrey; Katherine A Marsden; David M Jupe
Journal:  J Clin Pathol       Date:  2006-06-02       Impact factor: 3.411

2.  A comparative study of anticoagulant control in patients on long-term warfarin using home and hospital monitoring of the international normalised ratio.

Authors:  M J E Bradbury; G Taylor; P Short; M D Williams
Journal:  Arch Dis Child       Date:  2007-08-03       Impact factor: 3.791

3.  Validity of CoaguChek S for home monitoring of anticoagulant therapy in pediatrics.

Authors:  James Hill; Sébastien Perreault; Michel Dorval
Journal:  Can J Cardiol       Date:  2007-01       Impact factor: 5.223

4.  Home INR monitoring of oral anticoagulant therapy in children using the CoaguChek S point-of-care monitor and a robust education program.

Authors:  Fiona Newall; Paul Monagle; Linda Johnston
Journal:  Thromb Res       Date:  2005-09-15       Impact factor: 3.944

5.  Capillary whole blood monitoring of oral anticoagulants in children in outpatient clinics and the home setting.

Authors:  V Marzinotto; P Monagle; A Chan; M Adams; P Massicotte; M Leaker; M Andrew
Journal:  Pediatr Cardiol       Date:  2000 Jul-Aug       Impact factor: 1.655

6.  Reliability, validity and ease of use of a portable point-of-care coagulation device in a pharmacist-managed anticoagulation clinic.

Authors:  Annie Lizotte; Isabelle Quessy; Marie-Claude Vanier; Josée Martineau; Stéphanie Caron; Martin Darveau; Alain Dubé; Edith Gilbert; Normand Blais; Lyne Lalonde
Journal:  J Thromb Thrombolysis       Date:  2002-12       Impact factor: 2.300

7.  Oral anticoagulant treatment in children based on monitoring at home.

Authors:  S Mähönen; P Riikonen; R L Väätäinen; T Tikanoja
Journal:  Acta Paediatr       Date:  2004-05       Impact factor: 2.299

  7 in total
  2 in total

1.  Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Paul Monagle; Anthony K C Chan; Neil A Goldenberg; Rebecca N Ichord; Janna M Journeycake; Ulrike Nowak-Göttl; Sara K Vesely
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

2.  Management of warfarin in children with heart disease.

Authors:  William T Mahle; Scott A Simpson; Paulette Fye; Michael E McConnell
Journal:  Pediatr Cardiol       Date:  2011-04-17       Impact factor: 1.655

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.